CRS-Group > about us > legal statements 

Disclaimer

The CRS-Andernach Group maintains this website to provide information on CRS services and to enhance public access on information about its initiatives and policies in general. Our goal is to keep this information timely and accurate. If errors are brought to our attention, we will correct them as soon as possible.  

CRS may review the website from time to time by updating this posting. However, CRS accepts no responsibility or liability with regard to the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected. All offers are not-binding and without obligation. Parts of the page or the complete publication including all offers and information might be extended, changed or partly or completely deleted by the author without separate announcement.  

CRS is not responsible for any contents linked or referred to from its pages - unless it has full knowledge of illegal contents and would be able to prevent the visitors of its site from viewing those pages. If any damage occurs by the use of information presented there, only the author of respective pages might be liable, not one who has linked to these pages.

It is our goal to minimise disruption caused by technical errors. However, some data may have been created or structured on files or formats that are not error-free and we cannot guarantee that our service will not be affected by such problems.

CRS accepts no responsibility with regard to such problems incurred as a result of using our website or any linked external sites.

This disclaimer is not intended to limit the liability of CRS in contravention of any requirements laid down in applicable German law, nor to exclude its liability for matters which may not be excluded under that law.

Informationen für Probanden

Wenn Sie uns als Proband bei der Entwicklung neuer Medikamente unterstützen möchten, besuchen Sie bitte www.probandeninfo.de.